Home
Our Technology
Innovative Chemistry
Transformative Therapies
FDA โFast Trackโ and โBreakthrough Therapyโ designations received.


About us
What We Do
Weโre a biotech company committed to stemming the prescription drug abuse epidemic.
Our Strategy
Delivering
Innovative Technology
-
TAAPโข Preventing drug abuse
A highly novel platform that reduces the possibility of abuse by snorting, extracting, injection or chewing.
-
Universal Application
Our technology can be applied to a large complement of oral prescription drugs
-
MPARยฎ Preventing drug overdose
Our unique Multi-Pill Abuse Resistant technology MPARยฎ provides another layer of protection, reducing the possibility of overdose.
Our Team
Brilliant minds
and vision
Weโre proud to say our team is made up of just that โ people and minds both driven by passion and full of potential. Our company is led by a team of executives and directors with vast experience and proven track records in pain, drug development and commercialization.

D. Lynn Kirkpatrick, PhD
Chief Executive Officer
Dave Humphrey
Chief Financial Officer
Bill Schmidt, PhD
Chief Medical Officer.
Jeffrey Millard, PhD
Chief Operating Officer
Geoff Birkett
Chief Commercial Officer